EU clears Elanco/Bayer with pipeline product divestments
The European Commission has approved Elanco’s $7.6 billion purchase of Bayer’s animal health business, subject to the divestment of existing and pipeline products in the pet and livestock pharmaceutical markets.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.